Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

Details for Australian Patent Application No. 2009202361 (hide)

Owner Bristol-Myers Squibb Company

Inventors Ueda, Yasutsugu; Xue, Qiufen May; Meanwell, Nicholas A.; Kadow, John F.; Wang, Tao; Zhang, Zhongxing; Yin, Zhiwei; Regueiro-Ren, Alicia; Matiskella, John D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009202361

Parent 2003261367

Filing date 12 June 2009

Wipo publication date 2 July 2009

Acceptance publication date 13 October 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

2 July 2009 Application Open to Public Inspection

  Published as AU-B-2009202361

2 July 2009 Complete Application Filed

13 October 2011 Application Accepted

  Published as AU-B-2009202361

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202362-New uses for amino acid anticonvulsants

2009202360-Herbicidal composition